LBA6 - Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC
| Autor: | Rizvi, N.A., Chul Cho, B., Reinmuth, N., Lee, K.H., Ahn, M.-J., Luft, A., van den Heuvel, M., Cobo, M., Smolin, A., Vicente, D., Moiseyenko, V., Antonia, S.J., Le Moulec, S., Robinet, G., Natale, R., Nakagawa, K., Zhao, L., Stockman, P.K., Chand, V., Peters, S. |
|---|---|
| Zdroj: | In Annals of Oncology December 2018 29 Supplement 10:x40-x41 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|